Study reveals new therapeutic target for slowing the spread of flu virus

June 22, 2018, Perelman School of Medicine at the University of Pennsylvania
Flu shot. Credit: NIAID

Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, Ph.D., chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson. Their results also suggest that infection with flu A may reduce splicing of some host genes, which could point to novel strategies for antiviral therapies.

Influenza A is a common human pathogen that causes 250,000 to 500,000 deaths per year worldwide. "Although vaccines and some antiviral drugs are available, it is crucial to understand influenza virus-host interactions at a molecular level in order to identify host vulnerabilities targeted by flu viruses, which could lead to developing new therapeutic options," said Lynch, whose lab focuses on the specific mechanisms and patterns of alternative RNA splicing and how it relates to human disease,

The transcription of DNA into messenger RNA—the process of a single gene encoding a single —isn't as straightforward as once thought. The phenomenon of alternative RNA splicing—where a single gene can encode multiple proteins—was discovered over 30 years ago in viruses.

The flu A genome is comprised of eight single-strand segments of RNA. Three of these segments use alternative splicing to produce two essential viral proteins each, which are important in helping the virus gain entry into host cells. Working with cultures of human lung cells, the team's proposed mechanism of how flu A virus interacts with human RNA splicing machinery suggests that keeping human splicing proteins from binding to the would help to stop its replication.

As a result, the researchers found that mutating sequences of the viral genome to prevent host proteins from binding caused viral RNA to splice incorrectly and eventually halt replication—thus slowing the spread of the virus in the body.

A balance between the two viral messenger RNAs must be maintained for the virus to successfully infect host cells and replicate. "Regulating splicing of the two viral proteins is a fundamental step in viral-host interaction and so a potentially new anti-viral remedy," Lynch said.

For now, her team is refining their understanding of the intricacies of viral reproduction in host cells. Their hope is to one day identify a specific molecular target for antiviral medications that can be used in the clinic.

Explore further: Researchers capture first representative of most abundant giant viruses in the sea

More information: Matthew G. Thompson et al, Co-regulatory activity of hnRNP K and NS1-BP in influenza and human mRNA splicing, Nature Communications (2018). DOI: 10.1038/s41467-018-04779-4

Related Stories

Researchers capture first representative of most abundant giant viruses in the sea

March 29, 2018
Bodo saltans virus, the first isolated representative of the most abundant giant viruses in the sea, has been unveiled by researchers at the University of British Columbia.

Scientists established a comprehensive protein interactions map of the replication machinery of a chronic virus

December 20, 2017
Chronic viral infections like HIV or hepatitis are among the biggest threats to human health worldwide. While an acute viral infection usually results in full recovery and effective immune memory, chronic viruses evade the ...

Human genomic pathways to bronchitis virus therapy

November 18, 2015
Viral replication and spread throughout a host organism employs many proteins, but the process is not very well understood. Scientists at A*STAR have led a collaborative study to learn which host factors play a key role in ...

New insight about how viruses use host proteins to their advantage

April 2, 2018
Viruses have a very limited set of genes and therefore must use the cellular machineries of their hosts for most parts of their growth. A new study, led by scientists at Uppsala University, has discovered a specific host ...

Researchers discover possible new target to attack flu virus

April 10, 2014
(Medical Xpress)—Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially ...

Against the clock—uncovering the first 30 minutes of viral infection

March 29, 2018
Researchers are unraveling the crucial first 30 minutes of viral invasion into a human cell.

Recommended for you

Researchers seek vaccine for 'traveler's diarrhea'

September 25, 2018
Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ...

Experimental vaccine shows promise in preventing TB

September 25, 2018
(HealthDay)—Tuberculosis remains the most lethal of infectious diseases worldwide, killing more than 1.6 million people a year. But researchers say a new vaccine might prevent half of full-blown illnesses in infected people ...

Many doctors in India miss TB signs: study

September 25, 2018
Many private sector doctors in India miss the signs of tuberculosis and therefore provide patients inadequate treatment, according to a new study published Tuesday involving people hired to act out the symptoms.

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

rrwillsj
1 / 5 (2) Jun 23, 2018
A_B, pity that you didn't get treated for that syphilis that is causing you so much brain damage!

What? You spent your condom allowance on beer? You are a walking testimonial to bad decision making. With pitiful lack of self-discipline and having not a lick of common sense!

I hope all the girls and boys you infected have been treated? At your expense!

Have you no conscious?

Are you even capable of shame?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.